Intellipharmaceutics International Inc.
NASDAQ:IPCI (3/20/2019, 8:00:00 PM)
After market: 0.2151 +0 (+2.14%)0.2106
-0.06 (-22%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.7 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.13 | ||
| P/tB | N/A | ||
| EV/EBITDA | 0.02 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -119.81% | ||
| ROE | -335.12% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | -778.09% | ||
| PM (TTM) | -802.68% | ||
| GM | N/A | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.59 | ||
| Altman-Z | -13.59 |
ChartMill assigns a fundamental rating of 2 / 10 to IPCI.
ChartMill assigns a valuation rating of 3 / 10 to Intellipharmaceutics International Inc. (IPCI). This can be considered as Overvalued.
Intellipharmaceutics International Inc. (IPCI) has a profitability rating of 1 / 10.
The dividend rating of Intellipharmaceutics International Inc. (IPCI) is 0 / 10 and the dividend payout ratio is 0%.